Sharekhan

Aarti Pharmalabs Ltd

Thu 13/03/2025,15:59:55 | NSE : AARTIPHARM

₹ 738.957.75 (1.06%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 734.35

Previous Close

₹ 731.20

Volume

268984

Mkt Cap ( Rs. Cr)

₹6696.81

High

₹ 748.50

Low

₹ 726.60

52 Week High

₹ 837.25

52 Week Low

₹ 399.55

Book Value Per Share

₹ 204.88

Dividend Yield

0.00

Face Value

₹ 5.00

What’s Your Call?

Collective community sentiment on Aarti Pharmalabs Ltd

Your Vote -

Buy

85.71%

Hold

0.00%

Sell

14.29%

85.71%

7 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

738.95

499

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

499

Option Chain

Analyzes market sentiment, predicts Aarti Pharmalabs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Aarti Pharmalabs - Alteration Of Capital and Fund Raising-XBRL

    10 Mar 2025, 6:06PM AARTI PHARMALABS LIMITED has informed the Exchange regarding Allotment of Securities
  • Aarti Pharmalabs - ESOP/ESOS/ESPS

    10 Mar 2025, 5:53PM Aarti Pharmalabs Limited has informed the Exchange regarding Allotment of 8616 Shares.
  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    10 Mar 2025, 5:54PM Allotment of Shares under PSOP 2023
  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    12 Feb 2025, 4:40PM Transcript of Q3/9M Earnings Conference call
  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    12 Feb 2025, 4:40PM Aarti Pharmalabs Limited has informed the Exchange about Transcript
  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    7 Feb 2025, 6:30PM Recording of the Earnings Conference call for Q3 FY 25
  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    7 Feb 2025, 6:30PM Aarti Pharmalabs Limited has informed the Exchange about Link of Recording
  • Aarti Pharmalabs - Copy of Newspaper Publication

    7 Feb 2025, 11:33AM Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication
  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Investor Presentation

    6 Feb 2025, 4:42PM Investor Presentation for the Quarter ended December 31, 2024
  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Feb 2025, 4:42PM Aarti Pharmalabs Limited has informed the Exchange about Presentation
  • Aarti Pharmalabs has declared 50% Interim dividend for the financial year March 2025

    6 Feb 2025, 12:31PM Aarti Pharmalabs Ltd. on Wednesday, 05 February 2025, has announced Interim dividend of 50 percent on Equity Share, to its shareholders holding shares
  • Aarti Pharmalabs - Record Date For Interim Dividend

    5 Feb 2025, 7:36PM Record Date for Interim Dividend
  • Aarti Pharmalabs - Corporate Action-Board to consider Dividend

    5 Feb 2025, 7:35PM Board approved the Interim Dividend
  • Aarti Pharmalabs - Record Date

    5 Feb 2025, 7:34PM Aarti Pharmalabs Limited has informed the Exchange that Record date for the purpose of Dividend is 14-Feb-2025.
  • Aarti Pharmalabs - Outcome of Board Meeting-XBRL

    5 Feb 2025, 7:28PM Aarti Pharmalabs Limited has informed the Exchange regarding Outcome of Board Meeting held on 05-Feb-2025 for Dividend
  • Aarti Pharmalabs - Integrated Filing (Financial)

    5 Feb 2025, 7:26PM Integrated Filing (Financials) for the Quarter ended December 31, 2024
  • Aarti Pharmalabs - Integrated Filing- Financial

    5 Feb 2025, 7:22PM Integrated Filing (Financials)
  • Aarti Pharmalabs Q3 net profit jumps 52.56% at Rs 73.52 cr

    5 Feb 2025, 7:21PM The company reported standalone net profit of Rs 73.52 crore for the quarter ended December 31, 2024 as compared to Rs 48.19 crore in the same period
  • Aarti Pharmalabs - Financial Results For Quarter Ended December 31, 2024

    5 Feb 2025, 7:17PM Financials Results for Quarter ended December 31, 2024
  • Aarti Pharmalabs - Financial Result Updates

    5 Feb 2025, 7:16PM Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
  • Aarti Pharmalabs - Board Meeting Outcome for Financial Results For Quarter Ended December 31, 2024

    5 Feb 2025, 7:12PM Financial Results For Quarter Ended December 31, 2024
  • Aarti Pharmalabs - Dividend

    5 Feb 2025, 7:11PM Aarti Pharmalabs Limited has informed the Exchange that Board of Directors at its meeting held on February 05, 2025, declared Interim Dividend of 2.5
  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    28 Jan 2025, 11:50AM Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet
  • Aarti Pharmalabs - Board Meeting Intimation

    28 Jan 2025, 11:21AM AARTI PHARMALABS LIMITED has informed the Exchange about Board Meeting to be held on 05-Feb-2025 to consider and approve the Quarterly Audited Financi
  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    28 Jan 2025, 11:51AM This is to inform you that the Earnings Conference Call for Investors and Analysts, which would be a Group meet, has been scheduled on Friday, Februar
  • Aarti Pharmalabs - Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Nine-Months Ende

    28 Jan 2025, 11:20AM Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 ,inter alia, to consider and
  • Aarti Pharmalabs - Action(s) taken or orders passed

    18 Jan 2025, 3:16PM Aarti Pharmalabs Limited has informed the Exchange about Action(s) taken or orders passed
  • Aarti Pharmalabs - Re-Opening Of Manufacturing Activities At The Company'S Vapi Plant

    18 Jan 2025, 3:10PM Re-opening of Manufacturing activities at the Company's Vapi Plant
  • Aarti Pharmalabs has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    14 Jan 2025, 2:30PM As of December 2024, 44.66% is owned by Promoters and 55.34% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 44.48% and F
  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Acquisition

    9 Jan 2025, 5:07PM Acquisition by entering into a Power Purchase Agreement
  • Aarti Pharmalabs - Acquisition

    9 Jan 2025, 5:07PM Aarti Pharmalabs Limited has informed the Exchange about Acquisition
  • Aarti Pharmalabs - Closure Of Manufacturing Activities At The\r\nCompany'S Vapi Plant

    3 Jan 2025, 1:18PM Closure of manufacturing activities at Vapi Plant
  • Aarti Pharmalabs - Action(s) taken or orders passed

    3 Jan 2025, 1:17PM Aarti Pharmalabs Limited has informed the Exchange about Action(s) taken or orders passed
  • Aarti Pharmalabs - Trading Window-XBRL

    26 Dec 2024, 3:05PM AARTI PHARMALABS LIMITED has informed the Exchange about Closure of Trading Window
  • Aarti Pharmalabs - Trading Window

    26 Dec 2024, 3:03PM Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,
  • Aarti Pharmalabs - Agreements,Contracts,Arrangements,MOU-XBRL

    18 Dec 2024, 6:39PM AARTI PHARMALABS LIMITED has informed the Exchange regarding Shareholder agreements
  • Aarti Pharmalabs - Agreements

    17 Dec 2024, 11:06AM Aarti Pharmalabs Limited has informed the Exchange about Agreements
  • Aarti Pharmalabs - Disclosure under Regulation 30A of LODR

    17 Dec 2024, 11:03AM Intimation for signing of Shareholder's agreement

Key fundamentals

Evaluate the intrinsic value of Aarti Pharmalabs Ltd stock 

Name March-24 March-23 March-22
Assets 1872.2571 1645.2909 1608.9004
Liabilities 1872.2571 1645.2909 1608.9004
Equity 45.313 45.313 45.563
Gross Profit 346.1585 308.3352 179.7858
Net Profit 200.6454 171.7268 106.7261
Cash From Operating Activities 183.6944 228.6894 -64.8426
NPM(%) 13.35 11.36 11.34
Revenue 1502.1319 1511.2478 941.021
Expenses 1155.9734 1202.9126 761.2352
ROE(%) 10.8 9.24 5.74

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
14 Feb 2025 2.5 50 0 636.3
31 Jul 2024 1 20 0 520.05
2 40 0 557.85

Peers

Other companies within the same industry or sector that are comparable to Aarti Pharmalabs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 546.30 0.44 20.18 6674.51 35.34 0.55
Amines and Plasticizers Ltd 207.56 -3.66 27.75 4070.38 361.94 0.24
Grauer and Weil (India) Ltd 115.60 0.00 32.66 16771.71 322.62 0.43
HP Adhesives Ltd 45.32 -3.04 21.28 6796.88 111.94 0.00

Company Info

Our Company was incorporated as a public limited company under the Companies Act, 2013 in Gujarat, India pursuant to a certificate of incorporation dated November 22, 2019 issued by Registrar of Companies, Ahmedabad, Gujarat. The Corporate Identification Number (CIN) of the Company is U24100GJ2019PLC110964.Major events and milestone of our Company:2019Incorporation of the company. The Company had not commenced any business since its incorporation.2021The name of the Company was changed from `Aarti Organics Limited' to `Aarti Pharmalabs Limited'2022NCLT approved Scheme of Arrangement under the provisions of section 230 to 232 and other applicable provisions of the Companies Act, 2013 between Aarti Industries Limited and Aarti Pharmalabs Limited and their respective shareholders, sanctioned by the NCLT on September 21, 2022 (the certified true copy of the order was received on September 22, 2022). Pursuant to the Scheme, Pharma business of Aarti Industries Limited has been vested into the Company  2021 -Company name has changed to Aarti Pharmalabs Ltd. from Aarti Organics Ltd.

Our Company was incorporated as a public limited company under the Companies Act, 2013 in Gujarat, India pursuant to a certificate of incorporation dated November 22, 2019 issued by Registrar of Companies, Ahmedabad, Gujarat. The Corporate Identification Number (CIN) of the Company is U24100GJ2019PLC110964.Major events and milestone of our Company:2019Incorporation of the company. The Company had not commenced any business since its incorporation.2021The name of the Company was changed from `Aarti Organics Limited' to `Aarti Pharmalabs Limited'2022NCLT approved Scheme of Arrangement under the provisions of section 230 to 232 and other applicable provisions of the Companies Act, 2013 between Aarti Industries Limited and Aarti Pharmalabs Limited and their respective shareholders, sanctioned by the NCLT on September 21, 2022 (the certified true copy of the order was received on September 22, 2022). Pursuant to the Scheme, Pharma business of Aarti Industries Limited has been vested into the Company  2021 -Company name has changed to Aarti Pharmalabs Ltd. from Aarti Organics Ltd.

Read More

Parent Organisation

Aarti Pharmalabs Ltd.

Founded

22/11/2019

Managing Director

Mr.Narendra J Salvi

NSE Symbol

AARTIPHARMEQ

FAQ

The current price of Aarti Pharmalabs Ltd is ₹ 738.95.

The 52-week high for Aarti Pharmalabs Ltd is ₹ 748.50 and the 52-week low is ₹ 726.60.

The market capitalization of Aarti Pharmalabs Ltd is currently ₹ 6696.81. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Aarti Pharmalabs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Aarti Pharmalabs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aarti Pharmalabs Ltd shares.

The CEO of Aarti Pharmalabs Ltd is Mr.Narendra J Salvi, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT